Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermosensitive gel for ulcerative colitis
NCT02745678Phase 1Completed
- Sponsor
- Stanford University
- Start
- Jan 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Salcrozine in ulcerative colitis (UC), sponsored by Stanford University. Primary endpoints: Mayo Disease Activity Index and Safety. Started Jan 2016; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02745678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745678.